Why Is Protein-Energy Wasting Associated With Mortality in Chronic Kidney Disease?

被引:155
|
作者
Kovesdy, Csaba P. [1 ,2 ]
Kalantar-Zadeh, Kamyar [3 ,4 ]
机构
[1] Salem Vet Affairs Med Ctr, Div Nephrol, Salem, VA 24153 USA
[2] Univ Virginia, Dept Med, Charlottesville, VA USA
[3] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Nephrol & Hypertens, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Torrance, CA 90509 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Protein-energy wasting; mortality; chronic kidney disease; muscle wasting; obesity paradox; hypoalbuminemia; BODY-MASS INDEX; C-REACTIVE PROTEIN; NONTRADITIONAL RISK-FACTORS; SHORT DAILY HEMODIALYSIS; DIALYSIS PATIENTS; CARDIOVASCULAR-DISEASE; MAINTENANCE DIALYSIS; PLASMA GELSOLIN; REVERSE EPIDEMIOLOGY; OBESITY PARADOX;
D O I
10.1016/j.semnephrol.2008.10.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Observational studies in chronic kidney disease (CKD) populations consistently have shown the strong mortality-predictability of such markers of protein-energy wasting (PEW) as hypoalbuminemia, low serum cholesterol levels, low body mass index, and reduced dietary protein intake. Even though the PEW-mortality association data traditionally are reported mostly in maintenance dialysis patients, emerging studies extend the existence of these associations to predialysis stages of CKD. Paradoxic risk factor patterns (reverse epidemiology) for both obesity and cholesterol recently have been reported in predialysis CKD, underscoring the overwhelming impact of PEW, a short-term killer, on reversing the long-term effect of conventional cardiovascular risk factors. Multiple pathophysiologic mechanisms have been suggested to explain the link between PEW and mortality in CKD, including derangements in muscle, adipose tissue, and the gastrointestinal, hematopoietic, and immune systems; complications related to deficiencies of multiple micronutrients; and the maladaptive activation of the inflammatory cascade. In addition to well-described pathophysiologic mechanisms involved in the higher mortality seen with PEW, we also discuss the potential role of novel factors such as circulating actin, gelsolin, and proinflammatory high-density lipoprotein. Whether PEW is causally related to adverse outcomes in CKD needs to be verified in randomized controlled trials of nutritional interventions. The initiation of major clinical trials targeting nutritional interventions with the goal of improving survival in CKD offer the promise of extending the survival of this vulnerable patient population. © 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 50 条
  • [21] Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications
    Gracia-Iguacel, Carolina
    Gonzalez-Parra, Emilio
    Barril-Cuadrado, Guillermina
    Sanchez, Rosa
    Egido, Jesus
    Ortiz-Arduan, Alberto
    Carrero, Juan J.
    NEFROLOGIA, 2014, 34 (04): : 507 - 519
  • [22] Plasma pentraxin 3 in patients with chronic kidney disease:: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
    Tong, Mengli
    Carrero, Juan Jesus
    Qureshi, A. Rashid
    Anderstam, Bjorn
    Heimburger, Olof
    Barany, Peter
    Axelsson, Jonas
    Alvestrand, Anders
    Stenvinkel, Peter
    Lindholm, Bengt
    Suliman, Mohamed E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05): : 889 - 897
  • [23] Protein-energy wasting and uremic failure to thrive in children with chronic kidney disease: They are not small adults
    Noureddin Nourbakhsh
    Connie M. Rhee
    Kamyar Kalantar-Zadeh
    Pediatric Nephrology, 2014, 29 : 2249 - 2252
  • [24] A Practical Approach to Nutrition, Protein-Energy Wasting, Sarcopenia, and Cachexia in Patients with Chronic Kidney Disease
    Hanna, Ramy M.
    Ghobry, Lena
    Wassef, Olivia
    Rhee, Connie M.
    Kalantar-Zadeh, Kamyar
    BLOOD PURIFICATION, 2020, 49 (1-2) : 202 - 211
  • [25] Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease
    Kovesdy, Csaba P.
    George, Sajid M.
    Anderson, John E.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 90 (02): : 407 - 414
  • [26] Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics
    Perez-Torres, Almudena
    Garcia, M. Elena Gonzalez
    Jose-Valiente, Belen San
    Rubio, M. Auxiliadora Bajo
    Diez, Olga Celadilla
    Lopez-Sobaler, Ana M.
    Selgas, Rafael
    NEFROLOGIA, 2018, 38 (02): : 141 - 151
  • [27] Protein-energy wasting and uremic failure to thrive in children with chronic kidney disease: They are not small adults
    Nourbakhsh, Noureddin
    Rhee, Connie M.
    Kalantar-Zadeh, Kamyar
    PEDIATRIC NEPHROLOGY, 2014, 29 (12) : 2249 - 2252
  • [28] Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting
    Yuan, Jiangzi
    Watanabe, Makoto
    Suliman, Mohamed
    Qureshi, Abdul Rashid
    Axelsson, Jonas
    Barany, Peter
    Heimburger, Olof
    Stenvinkel, Peter
    Lindholm, Bengt
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (02) : 274 - 282
  • [29] Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease
    Kaynar, Kubra
    Kural, Birgul V.
    Ulusoy, Sukru
    Cansiz, Muammer
    Akcan, Buket
    Misir, Nuray
    Yaman, Selcuk
    Kaya, Nuh
    HEMODIALYSIS INTERNATIONAL, 2014, 18 (01) : 153 - 162
  • [30] The Efficacy and Safety of Megestrol Acetate in Protein-Energy Wasting due to Chronic Kidney Disease: A Systematic Review
    Wazny, Lori D.
    Nadurak, Stewart
    Orsulak, Cali
    Giles-Smith, Lori
    Tangri, Navdeep
    JOURNAL OF RENAL NUTRITION, 2016, 26 (03) : 168 - 176